---
pmid: '12208510'
title: Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508
  cystic fibrosis transmembrane conductance regulator.
authors:
- Okiyoneda T
- Wada I
- Jono H
- Shuto T
- Yoshitake K
- Nakano N
- Nagayama S
- Harada K
- Isohama Y
- Miyata T
- Kai H
journal: FEBS Lett
year: '2002'
full_text_available: false
doi: 10.1016/s0014-5793(02)03134-4
---

# Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmembrane conductance regulator.
**Authors:** Okiyoneda T, Wada I, Jono H, Shuto T, Yoshitake K, Nakano N, Nagayama S, Harada K, Isohama Y, Miyata T, Kai H
**Journal:** FEBS Lett (2002)
**DOI:** [10.1016/s0014-5793(02)03134-4](https://doi.org/10.1016/s0014-5793(02)03134-4)

## Abstract

1. FEBS Lett. 2002 Aug 28;526(1-3):87-92. doi: 10.1016/s0014-5793(02)03134-4.

Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 
cystic fibrosis transmembrane conductance regulator.

Okiyoneda T(1), Wada I, Jono H, Shuto T, Yoshitake K, Nakano N, Nagayama S, 
Harada K, Isohama Y, Miyata T, Kai H.

Author information:
(1)Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, 
Kumamoto University, Kumamoto 862-0973, Japan.

Abnormal retention of Delta F508 CFTR (cystic fibrosis transmembrane conductance 
regulator) in the endoplasmic reticulum is a major cause of cystic fibrosis 
(CF). We show that calnexin Delta 185-520 but not calnexin can partially reverse 
the mislocalization of Delta F508 CFTR. This 256-amino acid protein has neither 
the transmembrane domain nor the P domain of calnexin. Calnexin Delta 185-520 
interacted with CFTR directly, and was secreted into the extracellular 
compartment over time. Forty-eight hours after transfection into CHO cells, 
calnexin Delta 185-520 increased the conversion of immature Delta F508 CFTR into 
mature Delta F508 CFTR. In immortalized human CF cell lines expressing Delta 
F508 CFTR, a halide efflux assay showed that calnexin Delta 185-520 partially 
restored CFTR function. These data indicate that calnexin Delta 185-520 may give 
a clue to develop the therapeutic way of cystic fibrosis with Delta F508 CFTR.

DOI: 10.1016/s0014-5793(02)03134-4
PMID: 12208510 [Indexed for MEDLINE]
